Simultaneous Hepatic and Visceral Resection: Preoperative Risk Stratification and Implications on Return to Intended Oncologic Therapy Andrew J. SinnamonEric LuoDaniel A. Anaya Gastrointestinal Oncology 23 November 2022 Pages: 1772 - 1783
ASO Author Reflections: Simultaneous Hepatic and Visceral Resection—A Bird in the Hand or Two in the Bush? Andrew J. SinnamonDaniel A. Anaya Aso Author Reflections 17 December 2022 Pages: 1784 - 1785
ASO Visual Abstract: Simultaneous Hepatic and Visceral Resection- Preoperative Risk Stratification and Implications on Return to Intended Oncologic Therapy Andrew J. SinnamonEric LuoDaniel A. Anaya Aso Visual Abstract 02 December 2022 Pages: 1786 - 1786
Immunotherapy for GI Malignancies, Ready for Prime Time? Andrew D. TieniberJuanes E. PerezRonald P. DeMatteo Gastrointestinal Oncology 22 October 2022 Pages: 1787 - 1793
ASO Visual Abstract: Immunotherapy for GI Malignancies, Ready for Prime Time? Andrew D. TieniberJuanes E. PerezRonald P. DeMatteo Aso Visual Abstract 12 December 2022 Pages: 1794 - 1794
Penetrance of Gastric Adenocarcinoma Susceptibility Genes: A Systematic Review Sahar HosseiniAhmet AcarKevin Hughes Gastrointestinal Oncology 17 December 2022 Pages: 1795 - 1807
Risk Stratification of Sentinel Node Metastasis Disease Burden and Phenotype in Stage III Melanoma Patients Zahra HussainMartin J. HeatonMarc D. Moncrieff Melanoma Open access 29 November 2022 Pages: 1808 - 1819
ASO Author Reflections: Risk Stratification of Sentinel Node Metastases in Stage III Melanoma Patients in the Era of Adjuvant Systemic Therapy Zahra HussainMarc Moncrieff ASO Author Reflections Open access 20 December 2022 Pages: 1820 - 1821
ASO Visual Abstract: Risk Stratification of Sentinel Node Metastasis Disease Burden and Phenotype in Stage III Melanoma Patients Zahra HussainMartin J. HeatonMarc D. Moncrieff Aso Visual Abstract 29 November 2022 Pages: 1822 - 1822
Prophylactic Lymphaticovenous Anastomosis Performed with Lymphadenectomy is Oncologically Safe for Melanoma Thomas Y. XiaCagri CakmakogluBrian R. Gastman Melanoma 05 December 2022 Pages: 1823 - 1829
ASO Author Reflections: Prophylactic Lymphaticovenous Anastomosis Performed with Lymphadenectomy is Oncologically Safe for Melanoma Thomas XiaCagri CakmakogluBrian Gastman Aso Author Reflections 04 January 2023 Pages: 1830 - 1830
ASO Visual Abstract: Prophylactic Lymphaticovenous Anastomosis Performed with Lymphadenectomy is Oncologically Safe for Melanoma Thomas Y. XiaCagri CakmakogluBrian R. Gastman Aso Visual Abstract 10 January 2023 Pages: 1831 - 1831
The Landmark Series: Scoring Systems for Primary Peritoneal Surface Malignancy Chukwuemeka Ihemelandu Peritoneal Surface Malignancy 22 December 2022 Pages: 1832 - 1837
ASO Author Reflections: Prognosticating the Treatment Outcome for Primary Peritoneal Surface Malignancy: Time for an Overhaul of Scoring Systems? Chukwuemeka Ihemelandu ASO Author Reflections 11 January 2023 Pages: 1838 - 1839
Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative Eliza W. BealShruthi SrinivasJordan M. Cloyd Peritoneal Surface Malignancy 30 October 2022 Pages: 1840 - 1849
ASO Visual Abstract: Conditional Survival After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative Eliza W. BealShruthi SrinivasJordan M. Cloyd Aso Visual Abstract 23 November 2022 Pages: 1850 - 1851
Cytoreduction and HIPEC for Gastric Carcinomatosis: Multi-institutional Analysis of Two Phase II Clinical Trials Benjamin L. GreenAlisa N. BlumenthalerJeremy L. Davis Peritoneal Surface Malignancy 08 November 2022 Pages: 1852 - 1860
ASO Visual Abstract: Cytoreduction and HIPEC for Gastric Carcinomatosis: Multi-institutional Analysis of Two Phase II Clinical Trials Benjamin L. GreenAlisa N. BlumenthalerJeremy L. Davis ASO Visual Abstract 25 November 2022 Pages: 1861 - 1862
Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases Antoine El AsmarMartin DelcourtGabriel Liberale Peritoneal Surface Malignancy Open access 09 November 2022 Pages: 1863 - 1869
ASO Author Reflections: Preoperative Serological Biomarkers as Novel Prognostic Factors in Patients with Peritoneal Metastases of Colorectal Cancer Origin Antoine El AsmarGabriel Liberale ASO Author Reflections 06 November 2022 Pages: 1870 - 1871
ASO Visual Abstract: Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases Antoine El AsmarMartin DelcourtGabriel Liberale ASO Visual Abstract 19 November 2022 Pages: 1872 - 1873
Similar Survival Among All Subtypes of Mucinous Appendiceal Adenocarcinoma Except the Intermediate Subtype, Which Shows an Improved Survival Paul H. SugarbakerDavid ChangJohn J. Liang Peritoneal Surface Malignancy 21 December 2022 Pages: 1874 - 1885
ASO Author Reflections: Similar Survival of All Subtypes of Mucinous Appendiceal Adenocarcinoma Except the Intermediate Subtype Which Shows an Improved Survival Paul H. SugarbakerDavid ChangJohn J. Liang Aso Author Reflections 08 December 2022 Pages: 1886 - 1888
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases Daryl K. A. ChiaRaghav SundarWei Peng Yong Peritoneal Surface Malignancy 23 December 2022 Pages: 1889 - 1890
Patient-Reported Outcomes of Breast Reconstruction: Does the Quality of Decisions Matter? Shibani R. ChettriMichael P. PignoneClara N. Lee Reconstructive Oncology 27 November 2022 Pages: 1891 - 1900
ASO Author Reflections: Breast Reconstruction Decision Quality and Patient-Reported Outcomes Shibani R. ChettriClara N. Lee Aso Author Reflections 05 January 2023 Pages: 1901 - 1901
ASO Visual Abstract: Patient-Reported Outcomes of Breast Reconstruction: Does the Quality of Decisions Matter? Shibani R. ChettriMichael P. PignoneClara N. Lee Aso Visual Abstract 04 January 2023 Pages: 1902 - 1903
Optimizing the Timeliness of Surgical Therapy in Patients with Breast Cancer Undergoing Immediate Breast Reconstruction Tyler SbrocchiKaitlin KavanaghAlbert H. Chao Reconstructive Oncology 19 November 2022 Pages: 1904 - 1910
ASO Author Reflections: Refining the Integration of Reconstructive Surgery into Breast Cancer Care Albert H. Chao ASO Author Reflections 18 November 2022 Pages: 1911 - 1911
ASO Visual Abstract: Optimizing the Timeliness of Surgical Therapy in Breast Cancer Patients Undergoing Immediate Breast Reconstruction Tyler SbrocchiKaitlin KavanaghAlbert H. Chao Aso Visual Abstract 17 December 2022 Pages: 1912 - 1913
Functional Outcome Following Proximal Tibial Osteosarcoma Resection and Reconstruction by Modular Endoprosthesis Walid Atef EbeidMohammad Hassan Abd-Ellatif Hassan Sarcoma Open access 27 November 2022 Pages: 1914 - 1925